初稿截稿日期：2019-01-29

摘要截稿日期：2019-01-29

终稿截稿日期：2019-07-31

Scope of the Congress:

The main scope of the conference is to interchange and advance the data from varied Scientists, analysts, academicians. In addition the most important stage to achieve large data with wide acclaimed speakers, latest ways, strategies, and also the most up to now makeovers and emerging approach for disease treatment and prevention of individual person health.

Guidelines for Speakers:

The meeting room is equipped with digital projector, screen & laptop, and we encourage speakers to submit the slides 3 days prior to the event. However, you can use your own laptops for the presentation and/or demonstration under unavoidable conditions. Please let us know if you need any other special requirements or software’s to be installed in the podium laptop.

Speakers have 20 minutes for their talk, plus time for questions (controlled by session chair).

Guidelines for Poster Presenters:

Poster boards (1 meter x 1 meter) with poster numbers and pasting materials will be provided to each presenter. We encourage you to paste the posters 1 hour prior to the start time of poster sessions as per the final program.

Poster evaluation and Certificate distribution will be done by the judges. Poster awards will be presented on day 3 during closing ceremony.

Certification:

All the attendees will be provided with delegate certification signed by the organizing committee member. Name and affiliation on the certificates will be printed on certificates as per our records, for any changes or requests regarding the certification— please contact us before one month of the conference.

E-Poster Presentation:

E-Posters Presenter is not required to join the conference in person. The Poster ( in PDF form ) will be electronically projected during the poster session area. E poster abstract will be published in abstract book proceedings. Presenters will be provided with E-certificate during the post conference works.

EPMC 2019 Scientific Sessions:

1. Patient-Centered Care

2. Precision Public Health

3. Personalized therapies

4. Product Development and Commercialization Challenges

5. Disease Prevention Strategies and Medical Treatments

6. Rare Diseases/Disorders and Orphan Drugs

7. Biomarkers and Precision Medicine

8. Pharmacogenomics and Precision Medicine

9. Precision Immunotherapy

10. Big Data for Precision Medicine

11. Companion Diagnostics in Precision Medicine

12. Theragnosis

13. Ethics in precision medicine

14. Regulatory Affairs

15. Precision diagnostics

16. Wearable technology : Precision Medicine

17. Artificial intelligence : Precision medicine

18. Precision medicine in guiding clinical trials

19. Translational Informatics

20. Diversity in Precision Medicine

21. Gene Editing, Microbiome and Neoantigens

Ewa Danuta Bialek

Institute Of Psychosynthesis®, Poland

Edmund Pezalla

Enlightenment Bioconsult, LLC, USA

Sergey Suchkov

Sechenov University, Russia

Kenji Suzuki

Tokyo Institute Of Technology, Japan

Henry M. Sobell

University Of Rochester, USA

Antonio Ruggiero

Catholic University Of Rome, Rome

David I Smith

Mayo Clinic, USA

Rania Bakkar

Cedars-Sinai Medical Center, Los Angeles, CA, USA

Dionisio Acosta

Institute Of Health Informatics, University College London, UK